PK Profile

INVEGA TRINZA® delivers sustained plasma concentrations1,2

Pk Profile

No correlation to clinical effect

Due to the difference in median pharmacokinetic profiles between the 2 products (INVEGA TRINZA® [paliperidone palmitate] and INVEGA SUSTENNA® [paliperidone palmitate]), caution should be exercised when making a direct comparison of their pharmacokinetic properties.2

INVEGA TRINZA® provides a dosing interval that can be measured in seasons, not days1


With 3 months in between doses of INVEGA TRINZA®, your patients can spend less time having medication conversations and more time focusing on other aspects of their treatment plan.

References: 1. INVEGA TRINZA® [prescribing information]. Titusville, NJ: Janssen Pharmaceuticals, Inc.; March 2016. 2. Data on file. Janssen Pharmaceuticals, Inc., Titusville, NJ.